论文信息 - STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2. - 字舞流文

STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2.

M. Sekeres | V. Santini | A. Zeidan | G. Sanz | Zhijian Xiao | A. Giagounidis | M. V. Hoef | S. Hertle | F. Ma | Aristoteles Giagounidis